BL PharmTech Corp
KOSDAQ:065170
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shenzhen Asia Link Technology Development Co Ltd
SZSE:002316
|
CN |
|
W
|
Wong Engineering Corporation Bhd
KLSE:WONG
|
MY |
|
HKC International Holdings Ltd
HKEX:248
|
HK |
|
Inventure Growth & Securities Ltd
NSE:INVENTURE
|
IN |
|
Forval Telecom Inc
TSE:9445
|
JP |
|
G
|
GoLogiq Inc
OTC:GOLQ
|
US |
|
BT Group PLC
XETRA:BTQ
|
UK |
|
Hanwei Electronics Group Corp
SZSE:300007
|
CN |
|
G
|
Guangdong Tecsun Science & Technology Co Ltd
SZSE:002908
|
CN |
|
B
|
Bonia Corporation Bhd
KLSE:BONIA
|
MY |
BL PharmTech Corp
EPS (Diluted)
BL PharmTech Corp
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BL PharmTech Corp
KOSDAQ:065170
|
EPS (Diluted)
-₩225
|
CAGR 3-Years
21%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-3%
|
|
|
AmorePacific Corp
KRX:090430
|
EPS (Diluted)
₩3.4k
|
CAGR 3-Years
21%
|
CAGR 5-Years
46%
|
CAGR 10-Years
-9%
|
|
|
Amorepacific Group
KRX:002790
|
EPS (Diluted)
₩1.4k
|
CAGR 3-Years
22%
|
CAGR 5-Years
79%
|
CAGR 10-Years
-8%
|
|
|
Cosmax Inc
KRX:192820
|
EPS (Diluted)
₩10.8k
|
CAGR 3-Years
81%
|
CAGR 5-Years
38%
|
CAGR 10-Years
16%
|
|
|
LG H&H Co Ltd
KRX:051900
|
EPS (Diluted)
-₩6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
EPS (Diluted)
₩5.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
9%
|
|
BL PharmTech Corp
Glance View
BL Pharmtech Corp. engages in health food industry. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2002-11-19. The firm operates its business through four segments. The Health Functional Food Business segment is engaged in the manufacture and sale of products such as red ginsengs, diet foods and vitamins. The Cosmetics Business segment is engaged in the manufacture and sale of anti-aging skincare products and, among others. The Diagnostic and Medical Business segment is engaged in the manufacture and sale of diagnostic kits and other products. The Other segment is engaged in the distribution of health foods and other products.
See Also
What is BL PharmTech Corp's EPS (Diluted)?
EPS (Diluted)
-225
KRW
Based on the financial report for Sep 30, 2025, BL PharmTech Corp's EPS (Diluted) amounts to -225 KRW.
What is BL PharmTech Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-3%
Over the last year, the EPS (Diluted) growth was -106%. The average annual EPS (Diluted) growth rates for BL PharmTech Corp have been 21% over the past three years , 16% over the past five years , and -3% over the past ten years .
